Note

Li Auto Inc. Announces Put Right Notification for 0.25% Convertible Senior Notes due 2028

Retrieved on: 
Wednesday, March 27, 2024

BEIJING, March 27, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it is notifying holders of its 0.25% Convertible Senior Notes due 2028 (CUSIP No.

Key Points: 
  • BEIJING, March 27, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it is notifying holders of its 0.25% Convertible Senior Notes due 2028 (CUSIP No.
  • The Put Right expires at 5:00 p.m., New York City time, on Monday, April 29, 2024.
  • The 2024 Repurchase Date is an interest payment date under the terms of the Indenture and the Notes.
  • Holders of Notes may request the Company’s Put Right Notice from the paying agent, Deutsche Bank Trust Company Americas.

Cardlytics Prices $150.0 Million Convertible Senior Notes Offering

Retrieved on: 
Wednesday, March 27, 2024

ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks’ digital channels, today announced the pricing of its offering of $150.0 million aggregate principal amount of 4.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Key Points: 
  • ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks’ digital channels, today announced the pricing of its offering of $150.0 million aggregate principal amount of 4.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
  • Cardlytics also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $22.5 million aggregate principal amount of notes.
  • Cardlytics estimates that the net proceeds from the offering will be approximately $144.5 million (or approximately $166.3 million if the initial purchasers fully exercise their option to purchase additional notes), after deducting the initial purchasers’ discounts and commissions and Cardlytics’ estimated offering expenses.
  • This press release is not an offer to repurchase the 2025 Notes, and the offering of the notes is not contingent upon the repurchase of the 2025 Notes.

The AI revolution is here: Samsung brings Galaxy AI to more smartphones

Retrieved on: 
Tuesday, March 26, 2024

This expansion includes popular models, such as the Galaxy S23 series, Galaxy S23 FE , Galaxy Z Fold5 and Galaxy Z Flip5 .

Key Points: 
  • This expansion includes popular models, such as the Galaxy S23 series, Galaxy S23 FE , Galaxy Z Fold5 and Galaxy Z Flip5 .
  • Whether you’re upgrading to the Galaxy S23 series, Galaxy S23 FE , Galaxy Z Fold5 and Galaxy Z Flip5 , Verizon has the perfect plan to match your needs.
  • Availability: Samsung One UI 6.1 with Galaxy AI features will be provided at no charge to Verizon customers using the Galaxy S23 series, Galaxy S23 FE , Galaxy Z Fold5 and Galaxy Z Flip5 starting March 28.
  • Check out our feature video on Galaxy AI to learn more about this amazing new technology, and visit Verizon’s Samsung Galaxy page to find the Galaxy smartphone that’s perfect for you.

Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering

Retrieved on: 
Tuesday, March 26, 2024

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $800,000,000 aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”) in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).

Key Points: 
  • Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $800,000,000 aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”) in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).
  • The offering is expected to close on April 10, 2024, subject to certain customary closing conditions.
  • The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities.
  • Surgery Partners intends to use the net proceeds from this offering to redeem all of the Issuer’s outstanding 6.750% senior unsecured notes due July 1, 2025 and 10.000% senior unsecured notes due April 15, 2027, to pay the accrued interest on such notes and to pay related fees and expenses in connection with this offering and such redemptions.

Surgery Partners, Inc. Announces New Senior Notes Offering

Retrieved on: 
Tuesday, March 26, 2024

BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, $600,000,000 aggregate principal amount of senior unsecured notes due 2032 (the “Notes”).

Key Points: 
  • BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, $600,000,000 aggregate principal amount of senior unsecured notes due 2032 (the “Notes”).
  • The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities.
  • The terms of the Notes, including interest rate and principal amount, will depend on market conditions at the time of pricing and will be determined by negotiations among Surgery Partners and the initial purchasers of the Notes.
  • Surgery Partners intends to use the net proceeds from this offering to redeem all of the Issuer’s outstanding 6.750% senior unsecured notes due July 1, 2025 and 10.000% senior unsecured notes due April 15, 2027, to pay the accrued interest on such notes and to pay related fees and expenses in connection with this offering and such redemptions.

Cardlytics Announces Proposed Convertible Senior Notes Offering

Retrieved on: 
Tuesday, March 26, 2024

The notes will be senior, unsecured obligations of Cardlytics, will accrue interest payable semi-annually in arrears and will mature on April 1, 2029, unless earlier converted or repurchased by Cardlytics.

Key Points: 
  • The notes will be senior, unsecured obligations of Cardlytics, will accrue interest payable semi-annually in arrears and will mature on April 1, 2029, unless earlier converted or repurchased by Cardlytics.
  • Cardlytics expects to use a portion of the net proceeds from the offering to repurchase for cash a portion of its 1.00% convertible senior notes due 2025 (the “2025 Notes”) in privately negotiated transactions entered into concurrently with the pricing of the offering through one of the initial purchasers or its affiliate, as Cardlytics’ agent (each, a “note repurchase transaction”).
  • This press release is not an offer to repurchase the 2025 Notes, and the offering of the notes is not contingent upon the repurchase of the 2025 Notes.
  • Cardlytics cannot predict the magnitude of such market activity or the overall effect it will have on the price of the notes offered or Cardlytics’ common stock.

Maxeon Solar Technologies Announces Preliminary Fourth Quarter and Fiscal Year 2023 Results

Retrieved on: 
Monday, April 8, 2024

Non-GAAP operating expenses is defined as operating expenses excluding stock-based compensation and restructuring charges and fees.

Key Points: 
  • Non-GAAP operating expenses is defined as operating expenses excluding stock-based compensation and restructuring charges and fees.
  • We also use these non-GAAP measures internally to assess our business, financial performance and current and historical results, as well as for strategic decision-making and forecasting future results.
  • Given our use of non-GAAP measures, we believe that these measures may be important to investors in understanding our operating results as seen through the eyes of management.
  • This is excluded from our Adjusted EBITDA financial measure as it is non-recurring and not reflective of ongoing operating results.

Zoom unveils AI-powered collaboration platform, Zoom Workplace, to reimagine teamwork

Retrieved on: 
Monday, March 25, 2024

Ask AI Companion will provide a new way to interact with AI Companion across the Zoom platform.

Key Points: 
  • Ask AI Companion will provide a new way to interact with AI Companion across the Zoom platform.
  • Zoom Workplace , the company’s AI-powered collaboration platform, will deliver new innovations to help businesses reimagine teamwork, facilitate connections, improve productivity, and optimize flexible work experiences.
  • Zoom Workplace will elevate the Zoom experience with Zoom AI Companion so that all employees within a company can be more productive, collaborate better, and enhance their skills.
  • Tightly integrated with Zoom Workplace, Zoom Business Services empower customer-facing employees to provide exceptional experiences throughout the customer lifecycle.

Millicom (Tigo) announces proposed Offering of Senior Notes due 2032

Retrieved on: 
Monday, March 25, 2024

Luxembourg, March 25, 2024 – Millicom International Cellular S.A. (“Millicom”) today announced that it is commencing a private offering of Senior Notes due 2032 (the “Notes”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).

Key Points: 
  • Luxembourg, March 25, 2024 – Millicom International Cellular S.A. (“Millicom”) today announced that it is commencing a private offering of Senior Notes due 2032 (the “Notes”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).
  • Millicom expects to use a portion of the net proceeds from the issuance of the Notes to repay indebtedness outstanding under the DNB Loans (as defined below), with accrued interest.
  • Millicom expects to use any remaining net proceeds from the issuance of the Notes for the repayment, redemption, retirement or repurchase of existing indebtedness of Millicom and its subsidiaries and for other general corporate purposes.
  • This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

Bombardier Announces Pricing of its New Issuance of Senior Notes due 2031

Retrieved on: 
Friday, March 22, 2024

The new Senior Notes will carry a coupon of 7.250% per annum and will be sold at 99.75% of par (the “New Notes”).

Key Points: 
  • The new Senior Notes will carry a coupon of 7.250% per annum and will be sold at 99.75% of par (the “New Notes”).
  • The issuance of the New Notes is expected to close on or about April 4, 2024, subject to customary closing conditions.
  • This announcement does not constitute an offer to purchase or the solicitation of an offer to sell the New Notes, the 2026 Notes or the 2027 Notes.
  • Any redemption of the 2027 Notes or any other notes will be made pursuant to a notice of redemption under the indentures governing such notes.